Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 14

    Ministry of Science and Technology invites Concept Proposals for CAR T Cell therapy

    Ministry of Science and Technology invites Concept Proposals for CAR T Cell therapy

    Medical Dialogues Bureau9 March 2020 12:17 PM IST
    Delhi: Through a recent notice, Ministry of Science and Technology has invited Concept Proposals on approach to developing CAR T Cell therapy at an...
    TG Therapeutics gets USFDA Orphan Drug Designation for follicular lymphoma drug Umbralisib

    TG Therapeutics gets USFDA Orphan Drug Designation for follicular lymphoma drug Umbralisib

    Medical Dialogues Bureau9 March 2020 10:45 AM IST
    New York - TG Therapeutics, Inc.today announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation to umbralisib,...
    PM Modi gets emotional while interacting with beneficiaries of PMBJP

    PM Modi gets emotional while interacting with beneficiaries of PMBJP

    Medical Dialogues Bureau9 March 2020 9:00 AM IST
    New Delhi - Prime Minister Narendra Modi on Saturday got emotional after interacting with one of the beneficiaries of Pradhan Mantri Bhartiya...
    Hester Biosciences appoints Sahil Shah as CFO, Dr Rahul Srivastava as Vice President

    Hester Biosciences appoints Sahil Shah as CFO, Dr Rahul Srivastava as Vice President

    Medical Dialogues Bureau8 March 2020 11:00 AM IST
    Ahemdabad: Through a recent announcement Haster Biosciences has stated that Mr Sahil Shah has been appointed as CFO of Hester...
    Acacia Pharma gets USFDA nod of BARHEMSYS® (amisulpride) for Treatment, Prevention of PONV

    Acacia Pharma gets USFDA nod of BARHEMSYS® (amisulpride) for Treatment, Prevention of PONV

    Medical Dialogues Bureau8 March 2020 10:00 AM IST
    The approval for BARHEMSYS covers the treatment of PONV in patients who have received antiemetic prophylaxis with an agent of a different class or who...
    Takeda Receives Positive CHMP Opinion for Crohn Disease drug

    Takeda Receives Positive CHMP Opinion for Crohn Disease drug

    Medical Dialogues Bureau8 March 2020 9:15 AM IST
    Tokyo: Takeda Pharmaceutical Company Limited had announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...
    CryoLife receives CE Mark for hybrid stent graft system E-vita Open NEO™

    CryoLife receives CE Mark for hybrid stent graft system E-vita Open NEO™

    Medical Dialogues Bureau8 March 2020 9:00 AM IST
    The Company's hybrid stent graft technologies, which include the E-vita Open NEO and the E-vita Open Plus, enable a one-stage procedure treatment of...
    On sidelines of Janaushadi Diwas, PM Modi appeals for handwashing, habit of Namaste

    On sidelines of Janaushadi Diwas, PM Modi appeals for handwashing, habit of Namaste

    Medical Dialogues Bureau7 March 2020 4:00 PM IST
    Delhi: Jan aushadhi Diwas was celebrated on 7th March 2020. Prime minister Shri Narendra Modi interacted with owners of selected Jan aushadhi Kendras...
    Coronavirus: Restrictions imposed on some APIs, says Union Minister Mandaviya

    Coronavirus: Restrictions imposed on some APIs, says Union Minister Mandaviya

    Medical Dialogues Bureau7 March 2020 1:09 PM IST
    In the case of some APIs, a crisis may occur in the country in the future, if they are exported
    Granules receives USFDA nod for  Potassium Chloride Extended-Release Tablets USP

    Granules receives USFDA nod for Potassium Chloride Extended-Release Tablets USP

    Medical Dialogues Bureau7 March 2020 10:00 AM IST
    Potassium Chloride ER Tablets are used for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom...
    USFDA accepts regulatory submission for tanezumab for management of chronic pain  due to osteoarthritis

    USFDA accepts regulatory submission for tanezumab for management of chronic pain due to osteoarthritis

    Medical Dialogues Bureau7 March 2020 10:00 AM IST
    Tanezumab is a monoclonal antibody that is part of an investigational class of non-opioid chronic pain medications known as nerve growth factor (NGF)...
    Sanctions-hit Iran struggles to make cancer drugs: Report

    Sanctions-hit Iran struggles to make cancer drugs: Report

    Medical Dialogues Bureau7 March 2020 9:00 AM IST
    Iran: A lab-coated technician leans over a bioreactor at an Iranian pharmaceutical plant producing cancer drugs -- a tall order since equipment...
    PrevNext

    Popular Stories

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok